Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
two immune checkpoint inhibitors have been approved in combination with chemotherapy for PD-L1-positive advanced triple-negative breast cancer (TNBC).
Howard et al. 2022 Expert Opinion on Investigational Drugs 31(6): 531-548…